Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Minerva Endocrinologica 2017 September;42(3)

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

 

Minerva Endocrinologica 2017 September;42(3)

ORIGINAL ARTICLE  

Minerva Endocrinologica 2017 September;42(3):195-202

Continuous glucose monitoring and hypoglycemia unawareness in type 1 diabetes: a pilot study

Mohamed ZALZALI *, Valérie HOUDELET-GUERINOT, Eric SOCQUARD, Aurore THIERRY, Brigitte DELEMER, Céline LUKAS-CROISIER

Abstract PDF

ORIGINAL ARTICLE  

Minerva Endocrinologica 2017 September;42(3):203-12

Thyroid micro-carcinoma: only a diagnostic epidemic?

Paolo DEL RIO, Chiara, MONTANA MONTANA *, Giulia MINGARDI, Giovanna PIVA, Mario SIANESI, Luigi CORCIONE

Abstract PDF

ORIGINAL ARTICLE  

Minerva Endocrinologica 2017 September;42(3):213-22

The impact of combined interpretation of localization studies on image-guided surgical approaches for primary hyperparathyroidism

Fatih TUNCA *, Murat AKICI, Yalın IŞCAN, Ismail CEM SORMAZ, Yasemin GILES SENYUREK, Tarık TERZIOĞLU

Abstract PDF

ORIGINAL ARTICLE  

Minerva Endocrinologica 2017 September;42(3):223-7

The value of color Doppler ultrasound in the diagnosis of lower extremity vascular disease in type 2 diabetes and an analysis of related factors

Le JIANG, Yuehua ZHAO *

Abstract PDF

REVIEW  

Minerva Endocrinologica 2017 September;42(3):228-37

Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes

Alessandro, MANDURINO-MIRIZZI, Sergio LEONARDI, Chiara MELLONI *

Abstract PDF

REVIEW  

Minerva Endocrinologica 2017 September;42(3):238-47

Novel acquisitions in the diagnosis of medullary thyroid carcinoma

Pierpaolo TRIMBOLI *, Anna CRESCENZI, Enrico SAGGIORATO, Giorgio TREGLIA, Luca GIOVANELLA

Abstract PDF

REVIEW  

Minerva Endocrinologica 2017 September;42(3):248-70

Fibroblast growth factors: new insights, new targets in the management of diabetes

Ioannis KYROU, Martin O. WEICKERT, Seley GHARANEI, Harpal S. RANDEVA, Bee K., TAN *

Abstract PDF

REVIEW  

Minerva Endocrinologica 2017 September;42(3):271-9

The possible impact of advanced glycation end products on pregnancy outcome in women with diabetes mellitus type 1

Magdalena, PERTYNSKA-MARCZEWSKA *, Katarzyna CYPRYK

Abstract PDF

REVIEW  

Minerva Endocrinologica 2017 September;42(3):280-9

Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways

Chandrasekaran JAIKANTH, Prema GURUMURTHY *, Thillai INDHUMATHI, Kotturathu M., CHERIAN

Abstract PDF

LETTERS TO THE EDITOR  

Minerva Endocrinologica 2017 September;42(3):290-1

The complexity of elucidating whether novel mutations in the hepatocyte nuclear factor one alpha gene are responsible for maturity onset diabetes of the young in ethnic minorities

Pinky KURANI*, Devin STEENKAMP

PDF

LETTERS TO THE EDITOR  

Minerva Endocrinologica 2017 September;42(3):291-4

Difficult management in parathyroid carcinoma with synchronous parathyroid hyperplasia

Fabio PAGNI, Giovanni CASELLA *, Francesca M. BOSISIO, Marilena COSTANTINI, Giannantonio FIORETTA, Guglielmo NICOLETTI, Vittorio BALDINI, Camillo DI BELLA

PDF

LETTERS TO THE EDITOR  

Minerva Endocrinologica 2017 September;42(3):294-6

Cardiovascular disease in PCOS is related to severe insulin resistance, not mild

Michael H., DAHAN *, Fahim ABBASI, Gerald M. REAVEN

PDF

inizio pagina